By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Business of developing and commercializing innovative ophthalmic products for the treatment of eye31.37M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States (U.S.)29.98M95.56%
China1.29M4.12%
United Kingdom (UK)100K0.32%